Breast Cancer Prognosis Not Affected By Use Of HRT
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Breast Cancer Prognosis Not Affected By Use Of HRT

LONDON, UK -- February 4, 2000 -- Some studies have suggested that women using hormone replacement therapies, who get breast cancer, develop tumours with "favourable" pathological features compared to women who get breast cancer and who do not use such therapies.

In this week's BMJ a study conducted in Scotland finds that there is no evidence to suggest that women using hormone replacement therapies develop tumours with favourable prognostic features, however, nor do they develop poorer prognosis tumours, which the authors say is reassuring.

Dr Sheila Stallard and colleagues from North Glasgow Hospitals University NHS Trust and the Cancer Surveillance Unit at the University of Glasgow studied 1113 women aged 50-64 years of age who underwent routine breast screening between May 1988 and December 1993. The screening was undertaken in the region covered by the West of Scotland Breast Screening Unit and each of the 1113 women had either a screen detected cancer or had developed cancer in between screens. Within this group the authors found that 166 (14.9 per cent) were using hormone replacement therapy at the time they developed breast cancer.

Stallard et al found no difference in the type, size or grade of tumour in women who were using hormone replacement compared with those who were not. They therefore conclude that the evidence presented in their study supports the view that using hormone replacement therapy gives neither favourable nor poorer prognosis to those women who develop breast cancer, which they say is reassuring.

Related links: hormone replacement therapies (HRT) and British Medical Journal.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities